The Global Cardiovascular Genetic Testing Market was valued at USD 11.21 Billion in 2025 and is expected to reach USD 26.22 Billion by 2033, growing at a CAGR of 11.2% (2026-2033).

The Genetic Testing market was valued at USD 21.49 Billion in 2024 and is expected to reach USD 72.93 Billion by 2032, growing at a CAGR of 16.5% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.